Cell permeable inhibitors of anaphase promoting complex
US9572788B2 · kind B2 · utility
0Cited by
3References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 13, 2014 |
| Grant date | Feb 21, 2017 |
| Priority date | — |
| Expiry date | May 13, 2034 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61N2005/109
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The disclosure provides compositions and methods for treating cell cycle disorders. Compositions of the disclosure include proTAME, a prodrug analog of TAME and apcin, the combination of which inhibits an activity or function of the anaphase promoting complex (APC) by a synergistic mechanism.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.